Professor Muneer is the urology clinical lead at UCLH and completed his MD at the Wolfson Institute of Biomedical Research, UCL where he investigated the role of ischaemia and smooth muscle dysfunction. This has led to a change in the management of ischaemic priapism with UCLH leading on the use of acute penile prosthesis insertion for refractory cases - a practice now incorporated into international guidelines. Following on from this, he developed a penile cancer tissue biobank at UCL which has led to a collaboration with the UCL Cancer Institute to perform the first whole exome sequencing for penile cancer. Currently he is the clinical lead and PI for the MRI-PET trial for staging inguinal nodes in penile cancer which has now recruited the largest number of patients for a penile cancer trial and the Chief Investigator for the NIHR funded VELRAD trial in penile cancer. There is ongoing work to develop in vitro models to investigate novel targeted therapies which will form the basis for a translational arm to the penile cancer research using cell lines and xenograft models. The penile cancer team are also investigating the life cycle of low risk HPV and continue to investigate novel imaging techniques for the management of clinically impalpable disease. 

As part of the European Reference Network, the UCLH penile cancer unit is now part of eUROGEN which is a collaborative work stream with other centres of excellence throughout Europe and Professor Muneer is the research lead for the penile cancer work stream.